Aurobindo Pharma Limited — JV/Acquisition, 09-02-2026: Acquisition

Aurobindo Pharma is acquiring up to a 26% stake in Garuda Renewables Private Limited for ₹66 crore. This strategic investment aims to secure renewable energy from wind and solar sources, anticipating substantial savings in power costs. The move significantly enhances Aurobindo's ESG profile by reducing carbon emissions, reinforcing its commitment to green energy. Garuda, a new special purpose vehicle focused on hybrid power projects, is backed by Ecoren Energy's strong track record in renewable development. This backward integration targets operational efficiency and sustainability.